Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer Therapy
Researchers publish new studies and findings in the area of breast cancer therapy
March 16th, 2006
New findings from the United States, Belgium and United Kingdom describe advances in breast cancer therapy. Study 1: Low-dose estrogen and fulvestrant is proposed as a debulking strategy to maintain tumor control in breast cancer patients. "Long-term antihormonal therapy is effective at controlling the recurrence of estrogen receptor (ER)-positive breast cancer, but there may be unanticipated consequences for the development of new forms of drug resistance. Laboratory studies of exhaustive antihormonal therapy demonstrate there are at least two phases of resistance to selective ER modulators (SERMs; tamoxifen and raloxifene) and to estrogen...
Source: Women's Health Weekly (2006-03-16)
|
